Loading ...

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide

Doxo-PLA/PLA-PEG
Type Complex Compound
Formula
Role raw materials

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
colloidal stability

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
female BALB/c mouse xenografted with osteosarcoma K7M2 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • doxorubicin-polylactide
  • poly(ethylene glycol)-b-polylactide
  1. wUwfFQt3rxTG
Product

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Physical formation
Source:
Product

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide nanoparticles

Hydrodynamic diameter: 50 - 150 nm

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial